Allarity Therapeutics Inc (ALLR) Quote

Can't argue with that not being the case, it's an outright major crime that the SEC lets these criminals in their cheap suits getaway with it,day in and day out, sure many start out believing they can become something that could turn into something good,but most turn into a toxic cesspools with no way out,other than becoming the self-centered selfish toxic slobs they become, and think they are doing nothing wrong ripping off the public and lining their pockets and over compensating themselves with greedy payouts,that none of them deserve,when the company's are using burning through cash to support their scam until the worthless brainless SEC some times do their usual half-ass job of shutting them down,after the retail public ends up losing many millions,to be one of them I guess you have to have a few bucks buyout a shell company and hype of some kind of BS that you have something great,and sucker in the public to believe the BS, and have a few cheap suits,for when you get involved with the toxic note dilution lenders,and the pump and dump promoters.

There is a reason many institutional investors won't invest in sub $5 stocks. They are generally all bottom feeding pump and dump scams. Dilution followed by reverse split followed by more dilution etc etc until Nasdaq finally boots them off the exchange. Jackass CEO and management give themselves bonuses just prior to bankruptcy and ride off into the sunset with all the money stole and have zero liability for the fraud they committed. Man, what a racket. How do I get in on it?

Funny how they are trying to scare share holders into voting yes for a RS, mean while they screwed over any one who got stuck in the last one they just did in May, $5.00 to $0.15 in just three months,great investment only if you were short, or a naked shorting hedge fund criminal enterprise, wouldn't be surprised if they themselves shorted their own stock back then, sure they want a RS so they can keep the toxic slob formula in place,and keep their over paid salaries from getting hit and cut in half,and keep sucking money out of it on the backs of the public.

I wonder if this will hit $1.00 it's moving pretty fast

8k was released

Looks like a short squeeze has started after hours .27 and climbing

ALLR...18... https://schrts.co/AshjZBCw...Could get squeezed here with some tight bands...🥳

BB bands are super tight on ALLR this could see a hard bounce up.

Absolute trash!! Been saying it for months but no one listens as usual!!

pretty much

In the toilet now

ALLR recieves a well notice trade accordingly

I haven’t been a shareholder long enough I guess. I didn’t get an email.
I guess to vote on the RS, stock options lol and new officers

gosh i don't know I usually just delete without looking much what does it look like?

Did u get an email to vote for the split?

agree

Getting an extension and postpone the split and get some good news is the only way we stave off the wolves

Someone just said short shares are over $3 million

yup lets see how far they take it down am also done buying.

I’m afraid to ave down again
Every time I have it plunges more

Yes big time

lol i was typing as you were posting yes we need g/news

yes I'm down a good bit also we need good news and hurry

Company needs to majorly combat this with some good news

that was ending 6-30

https://www.marketbeat.com/stocks/NASDAQ/ALLR/short-interest/
700,000 sold short in the last 2 wks

They are doing a good job. Lost my ass
Doesn’t help if the company may be selling too

I added a few today gulp all markets down today. the shorts are trying to destroy it

Selling is relentless brother. Where the hell does it all come from

That will be great

understood still think buyout

Well unfortunately they need to maintain a dollar to stay on the daq

17.5 m outstanding don't let people worry you about an RS

Gonna be tough sledding here. So much downward pressure due to the RS threat
Shorts and pump and dumpers have the upper hand

few hundred isn't wwhat I'm looking for I wants k's
look https://investorshub.advfn.com/Bottom-Swing-Plays-29717

Everyone dumped from 18 cents
Hoping news of new trial comes today

BUY out coming ??????????

Agreed. ALLR moving up hella quick.

Shorty could shit themselves here soon.

Stop sugar coating it.......say it like it is...........

Z

$ALLR THESE PARTS OF THE LAST PR STAND OUT TO ME. TELLS ME THEY ARE ACTIVELY LOOKING FOR PARTNERS OR BUYOUT. THEY HAVE GOTTEN VERY GOOD RESULTS, SO GOOD THEY STOPPED THE LAST TRIAL EARLY. YOU DON’T DO THAT UNLESS THE PATIENTS HAVE BENIFITTED. FDA COULD COME I AND FAST FRACK THIS. ITS JUST MEANT TO EXTEND LIFE ON ADVANCED OVARIAN CANCER PATIENTS. SOFAR THEY HAVE PROVED IT SHRINKS TUMOR SIZE.
“Not only does the safety profile stand out when compared to chemotherapies, which is often the alternative for this patient group, but the safety metrics are indeed also favorable when compared to first-generation PARP inhibitors. As we see it, stenoparib may represent the next-generation alternative for advanced ovarian cancer patients. Therefore, we are aggressively working with Dr. Moore and other leading experts to design a trial that will help advance and quicken stenoparib’s clinical progress toward registration with the FDA.”

“After conducting a detailed review of the stenoparib monotherapy trial data, including the data announced today, the Company has concluded that these data may be of significant interest among key oncologists, potential commercial partners, and other relevant stakeholders and therefore warrant presentation within a high-level scientific conference. Further release of these clinical data is intended to be staged to comply with the common rules of scientific conferences, which do not allow data to be published before the event.”

The PARP inhibitor market is expected to reach $22 billion in revenue by 2028, and has historically seen significant partnerships and acquisitions.

For example, one significant acquisition included a multi-asset deal potentially totaling $1.5 billion, which featured an advanced PARP inhibitor.

Allarity has exclusive global rights for the development and commercialization of stenoparib, which was originally developed by Eisai Co. Ltd. and was formerly known under the names E7449 and 2X-121.

More trash stinking up the markets!! Get this POS delisted and out of here!!

U too my man

Have a great 4th.

I’m thinking the same especially if it’s got the FDA involved

still holding all I still believe this will run. the next trial will really make it fly if its favorable.

Whatcha thinking on what is happening now bro?

Agreed, i loaded today at 20 cents

I think the shorts are giving share holders a gift at these prices, if this passes Phase three ---- look out shorty

Now would be a good time to throw everything and the kitchen sink to stabilize this and kill the short attack